Shares of Aster DM Healthcare skyrocketed 14 percent on October 14 after the company delivered a robust earnings performance for the July-September quarter.

The hospital chain reported a net profit of Rs 96.84 crore in the September, a stark turnaround from a net loss of Rs 30.79 crore in the same period last fiscal. Revenue also grew  16 percent on year to Rs 1,086 crore in Q2 FY25 as compared to Rs 934 crore in the base period.

Not just that, operational performance also improved significantly as EBITDA margin expanded to 21.4 percent in Q2 FY25, up from 16.8 percent in the year ago period.

“As we expand, with plans to surpass around 6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India," Dr Azad Moopen, Founder and Chairman, Aster DM Healthcare, said in an exchange filing.

Along those lines, Aster DM also plans to add over 1,800 more beds by FY27 along with the new addition of Aster Women and Child in Hyderabad with 300 beds.

At 10.05 am, shares of Aster DM Healthcare were trading at Rs 446.60 on the NSE. The solid quarterly performance also triggered a surge in volumes in the counter as 79 lakh shares changed hands so far, significantly higher than the one-month daily traded average of six lakh shares.

Coming to the first half of FY25, the company's payor mix improved with insurance business contribution at 30 percent, offset by lower scheme business. The company's flagship Aster Whitefield hospital (Bangalore) achieved nearly 67 percent occupancy levels and ARPOB (Average Revenue Per Occupied Bed) at Rs 70,000 in H1 FY25.

In addition, core hospital business delivered an operating EBITDA margin of 22.4 percent in H1 FY25, up from 19.1 percent in H1 FY24.